Slide 1: Q2 2026 Supplemental Financial Information
August 6, 2026 Q2 2026 Supplemental Financial Information
Slide 2: Use of Non-GAAP Financial Measures
Use of Non-GAAP Financial Measures Inogen has presented certain financial information in accordance with U.S. GAAP and also on a non-GAAP basis for the three and six months ended June 30, 2026, and June 30, 2025. The non-GAAP financial measures presented in this presentation are EBITDA, adjusted EBI
Slide 3: Q2 2026 Results
Q2 2026 Results Revenue by geographic region Total by Category Q2 2026 Revenue Year-Over-Year Change % of Total Revenue U.S. sales $42.3 million (2.3)% 44.5% International sales $41.3 million 14.8% 43.4% U.S. rentals $11.6 million (11.8)% 12.2% Total revenue $95.1 million 3.0% 100% Total constant cu
Slide 4: Reconciliation of GAAP to Non-GAAP: Adjusted EBITDA
Reconciliation of GAAP to Non-GAAP Adjusted EBITDA (in thousands) Three months ended June 30, Six months ended June 30, Non-GAAP EBITDA and Adjusted EBITDA 2026 2025 2026 2025 Net loss (GAAP) $ (3,850) $ (4,152) $ (12,174) $ (10,326) Non-GAAP adjustments: Interest income, net (861) (1,123) (1,741) (
Slide 5: Reconciliation of GAAP to Non-GAAP: Adjusted Financial Metrics
Reconciliation of GAAP to Non-GAAP Adjusted Financial Metrics (in thousands) Three months ended June 30, 2026 Research and Sales and General and Loss from Non-GAAP Financial Metrics Gross Profit Development Marketing Administrative Operations Net Loss Diluted EPS Financial Results (GAAP) $ 43,272 $
Slide 6: Reconciliation of GAAP to Non-GAAP: Adjusted Financial Metrics (in thousands)
Reconciliation of GAAP to Non-GAAP Adjusted Financial Metrics (in thousands) Six months ended June 30, 2026 Research and Sales and General and Loss from Non-GAAP Financial Metrics Gross Profit Development Marketing Administrative Operations Net Loss Diluted EPS Financial Results (GAAP) $ 81,135 $ 10
Slide 7: Reconciliation of GAAP to Non-GAAP: Free Cash Flow
Reconciliation of GAAP to Non-GAAP Free Cash Flow (in thousands) Three months ended June 30, Six months ended June 30, Non-GAAP Free Cash Flow 2026 2025 2026 2025 Operating Cash Flow $ 2,946 $ 4,350 $ (3,739) $ (12,440) Capital Expenditures (1,919) (3,870) (2,700) (5,908) Free Cash Flow $ 1,027 $ 48
Slide 8: Stock-Based Compensation
Stock-Based Compensation (in thousands) Three months ended June 30, Six months ended June 30, 2026 2025 2026 2025 Stock-based compensation expense by type of award: Restricted stock units $ 1,706 $ 2,205 $ 3,570 $ 4,213 Employee stock purchase plan 65 88 151 227 Total stock-based compensation expens
Slide 9: Improving lives through respiratory care.
Improving lives through respiratory care.